ALFA FinderBSE filing, NSE: CHEMTECH. Summary written from the filing by ALFA Finder's alert engine.
Chemtech Industrial Valves Ltd: key numbers
- Share price
- ₹60.28
- Market cap
- ₹108.1 Cr
- Revenue (annual)
- ₹30.17 Cr
- Net profit (annual)
- ₹5.02 Cr
- P/E (TTM)
- 26.9×Sector 52.1×
- Promoter holding
- 40.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemtech Industrial Valves Ltd
All →Chemtech Industrial Valves Q2 FY27 Results: Net Profit ₹2.5 Cr, Up 108.3% YoY
Chemtech Industrial Valves Ltd reported revenue from operations of ₹15.1 Cr (+196.1% YoY) and net profit of ₹2.5 Cr (+108.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.5 Cr · +108.3% YoY
Chemtech Industrial Valves Board Meeting Date
Chemtech Industrial Valves Ltd intimated a board meeting on November 12, 2026 to approve Q2/H1 unaudited results. Trading window stays closed from October 1 until 48 hours after results.
Chemtech Industrial Valves Other Announcement
Chemtech Industrial Valves Ltd submitted its Regulation 74(5) certificate for the quarter ended September 30, 2026, as required by SEBI.
Chemtech Industrial Valves Management Change
Chemtech Industrial Valves Ltd. re-appointed Mr. Puneet Pradeep Badkur as a Whole-time Director, as approved by shareholders during the 30th Annual General Meeting.
Chemtech Industrial Valves Annual General Meeting
Chemtech Industrial Valves Ltd held its 30th Annual General Meeting on September 30, 2026. Shareholders considered resolutions including adoption of financial statements and increasing investment limits under Section 186.
Chemtech Industrial Valves Annual General Meeting
Chemtech Industrial Valves Limited has scheduled its 30th Annual General Meeting for September 30, 2026, via video conferencing. The company also released its Annual Report 2025-26.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr